Breaking News Instant updates and real-time market news.

TSLA

Tesla

$333.78

-2.57 (-0.76%)

, CNP

CenterPoint Energy

$24.58

-0.21 (-0.85%)

10:09
11/26/19
11/26
10:09
11/26/19
10:09

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Hold from Buy at China Renaissance with analyst Carson Ng citing valuation. 2. CenterPoint Energy (CNP) downgraded to Market Perform from Outperform at Wells Fargo with analyst Sarah Akers saying she now now assumes the company will need $2.5B in equity funding in reaction to negative developments including, most recently, the Public Utilities Commission of Texas' cost of capital decision. 3. CymaBay (CBAY) was downgraded to Market Perform from Strong Buy at Raymond James, to Neutral from Overweight at Cantor Fitzgerald, as well as to Neutral from Buy at H.C. Wainwright and Roth Capital. 4. Molson Coors (TAP) downgraded to Market Perform from Outperform at BMO Capital with analyst Amit Sharma saying Molson's "persistently low" valuation and high free cash flow yield has failed to entice investors as its "structurally compromised" sales growth has been "too high a hurdle," even for deep-value investors. 5. Comerica (CMA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Ken Zerbe saying he sees "far more" net interest margin compression at Comerica by the end of 2020 than the median he expects at its peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TSLA

Tesla

$333.78

-2.57 (-0.76%)

CNP

CenterPoint Energy

$24.58

-0.21 (-0.85%)

CBAY

CymaBay

$1.34

(0.00%)

TAP

Molson Coors

$51.29

-1.125 (-2.15%)

CMA

Comerica

$70.06

-0.46 (-0.65%)

  • 07

    Jan

  • 21

    Jan

TSLA Tesla
$333.78

-2.57 (-0.76%)

11/22/19
ADAM
11/22/19
NO CHANGE
Target $375
ADAM
Buy
Tesla pickup unveiled with impressive specifications, says Canaccord
Canaccord analyst Jed Dorsheimer attended the Tesla "cybertruck" unveiling and came away impresses with its futuristic styling and impressive specifications which he believes are unique and will resonate with consumers leading to solid demand. Dorsheimer reiterated his buy rating and $345 price target on Tesla shares.
11/26/19
CHRS
11/26/19
DOWNGRADE
Target $346
CHRS
Hold
Tesla downgraded to Hold from Buy at China Renaissance
China Renaissance analyst Carson Ng downgraded Tesla to Hold from Buy with an unchanged price target of $346. The shares closed Monday up $3.30 to $336.34. The analyst cites valuation for the downgrade with the shares up 49% since September. Further, he expects the special design of the new Cybertruck to draw "polarized responses" from both consumers and investors. While "strong preorders" of Cybertruck show Tesla's potential to expand its product portfolio, the recent share price appreciation has at least partly factored in the positives associated with upcoming Model Y launches and Shanghai production, Ng tells investors in a research note.
11/22/19
JMPS
11/22/19
NO CHANGE
JMPS
Ford, GM buyers unlikely to make switch to Cybertruck, says JMP Securities
JMP Securities analyst Joseph Osha maintained a Market Perform rating on Tesla (TSLA) following the company's Cybertruck announcement event. The analyst sees the styling of the vehicle being a "tough sell" for most pickup buyers, and said it may be an option for a Lincoln Navigator or a Range Rover buyer, but has "a lot of difficulty imagining most F150 buyers making the switch." Osha also questioned whether the Cybertruck could be a real volume product for Tesla, or if it will be repeatedly be delayed, like Tesla's semi project.
11/22/19
FBCO
11/22/19
NO CHANGE
Target $200
FBCO
Underperform
Ford, GM can 'breathe sigh of relief' after Tesla event, says Credit Suisse
After Tesla (TSLA) unveiled its Cybertruck on Thursday night, Credit Suisse analyst Dan Levy says he expects expects the electric pickup truck to be a lifestyle vehicle, but amid a highly radical design, it is unclear who the core buyer will be. Levy thinks the legacy OEMs like Ford (F) and GM (GM) can "breathe a sigh of relief," as he doesn't expect Cybertruck to encroach on large pickup share. The analyst keeps an Underperform rating and $200 price target on Tesla shares.
CNP CenterPoint Energy
$24.58

-0.21 (-0.85%)

11/25/19
WELS
11/25/19
DOWNGRADE
Target $26
WELS
Market Perform
CenterPoint Energy downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Sarah Akers downgraded CenterPoint Energy to Market Perform from Outperform with a $26 price target.
11/26/19
WELS
11/26/19
DOWNGRADE
Target $26
WELS
Market Perform
Wells downgrades CenterPoint Energy to Market Perform on higher equity needs
As previously reported, Wells Fargo analyst Sarah Akers downgraded CenterPoint Energy to Market Perform from Outperform as she now now assumes the company will need $2.5B in equity funding in reaction to negative developments including, most recently, the Public Utilities Commission of Texas' cost of capital decision. Although she notes that CenterPoint shares have already meaningfully underperformed since the PUCT's decision, she does not expect outperformance absent a reconsideration by the PUCT or non-core asset sales that ease the equity needs, Akers tells investors. She set a $26 price target on CenterPoint shares.
11/21/19
LEHM
11/21/19
NO CHANGE
LEHM
Barclays makes seven rating changes in North America Power & Utilities
Following company updates from Q3 reports and the Edison Electric Institute Financial Forum Conference, combined with regulatory actions and relative performance, Barclays analyst Eric Beaumont updated adjusted his ratings and estimates in the North America Power & Utilities space. The analyst upgraded Duke Energy (DUK), Pinnacle West (PNW) and Alliant Energy (LNT) to Overweight from Equal Weight. Duke and Pinnacle West have "underperformed meaningfully based on idiosyncratic issues," says the analyst, who sees "compelling relative upside" in the stocks. Further, Alliant needs less equity than assumed and has improved regulatory treatment, adds Beaumont. The analyst also upgraded PNM Resources (PNM) to Equal Weight from Underweight following the stock's underperformance. Further, he downgraded both CenterPoint Energy (CNP) and PSEG (PEG) to Equal Weight from Overweight. CenterPoint appears to be headed towards a "significantly adverse" regulatory outcome for Houston Electric, and PSEG's Q3 disclosures resulted in lower earnings at PEGP Power, contends Beaumont. The analyst also downgraded Consolidated Edison (ED) to Underweight from Equal Weight. HE says the company received a fair order in the CECONY rate case, but will be challenged to hit the high end of the performance range.
11/21/19
LEHM
11/21/19
DOWNGRADE
Target $26
LEHM
Equal Weight
CenterPoint Energy downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Eric Beaumont downgraded CenterPoint Energy to Equal Weight from Overweight with a $26 price target.
CBAY CymaBay
$1.34

(0.00%)

11/26/19
CANT
11/26/19
DOWNGRADE
Target $2
CANT
Neutral
CymaBay downgraded to Neutral from Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle downgraded CymaBay Therapeutics to Neutral from Overweight with a price target of $2, down from $20. Though shares are trading currently below cash of $3 per share, the "unexpected histological effects present a challenge for further clinical development," Merle tells investors in a research note.
11/26/19
RAJA
11/26/19
DOWNGRADE
RAJA
Market Perform
CymaBay double downgraded at Raymond James after seladelpar setback
As previously reported, Raymond James analyst Steven Seedhouse double downgraded CymaBay to Market Perform from Strong Buy following the "unexpected setback" for seladelpar that has resulted in the company terminating or halting all programs for the drug. He cut his view on the probability of success in primary biliary cholangitis, the remaining indication being studied, to 25% from 90% and sees uncertainty for any path forward for the lead program, Seedhouse tells investors.
11/26/19
ROTH
11/26/19
DOWNGRADE
Target $2
ROTH
Neutral
CymaBay downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi downgraded CymaBay to Neutral from Buy with a price target of $2, down from $22, following the company's announcement of a clinical halt for seladelpar and subsequent call providing more details of histology findings. She walked away from CymaBay update call with more understanding of the atypical histological findings, but still remains uncertain regarding the cause and how the clinical halt will be resolved, Rahimi tells investors. She prefers to step to the sidelines while awaiting more clarity regarding timelines and casualty, the analyst added.
11/26/19
HCWC
11/26/19
DOWNGRADE
Target $2
HCWC
Neutral
CymaBay downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Ed Arce downgraded CymaBay Therapeutics to Neutral from Buy with a price target of $2, down from $16, after the company halted all clinical development of lead drug seladelpar. The analyst believes the drug is "probably done." However, he believes further share downside like "likely limited" with the company's current cash at approximately $200M or about $2.91 per share.
TAP Molson Coors
$51.29

-1.125 (-2.15%)

11/25/19
LEHM
11/25/19
DOWNGRADE
Target $54
LEHM
Equal Weight
Molson Coors downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Lauren Lieberman downgraded Molson Coors to Equal Weight from Overweight with a price target of $54, down from $59. Following "too many disappointments for too long," improved revenue trends will need to be apparent before investors are willing to re-engage with the story, Lieberman tells investors in a research note. As a result, the analyst feels a "wait and see" stance in warranted with respect to Molson Coors shares.
11/25/19
11/25/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Netflix (NFLX) downgraded to Underperform from Market Perform at Wells Fargo with analyst Steven Cahall saying he analyzed Netflix's cash estimates and has conviction in his 2019-2025 cumulative free cash flow forecast that's $18B below consensus. 2. Prudential (PRU) downgraded to Sell from Neutral at Citi with analyst Suneet Kamath saying previously, the analyst had been concerned with "when" Prudential would get back to above-peer growth and return on equity. Now, however, he's concerned "if" the company can get there, particularly if interest rates remain low. 3. CymaBay (CBAY) downgraded to In Line from Outperform at Evercore ISI and to Hold from Buy at Stifel. 4. ManTech (MANT) downgraded to Hold from Buy at SunTrust with analyst Tobery Sommer saying after the company's "above-average" organic growth of 10% this year, 2020 will be more "difficult," also noting that he sees his expected 10bp margin expansion next year as "adequately" priced in to the stock at current levels. 5. Molson Coors (TAP) downgraded to Equal Weight from Overweight at Barclays with analyst Lauren Lieberman saying after "too many disappointments for too long," improved revenue trends will need to be apparent before investors are willing to re-engage with the story. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/26/19
BMOC
11/26/19
DOWNGRADE
Target $55
BMOC
Market Perform
Molson Coors downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Amit Sharma downgraded Molson Coors Brewing to Market Perform from Outperform with a price target of $55, down from $62. The shares closed Monday up 12c to $42.42. Molson's "persistently low" valuation and high free cash flow yield has failed to entice investors as its "structurally compromised" sales growth has been "too high a hurdle," even for deep-value investors, Sharma tells investors in a research note. Further, management's revitalization plan to lift sales growth does not go far enough to structurally lift the company's outlook and it may delay potentially shareholder-friendly strategic actions, adds the analyst.
11/20/19
EVER
11/20/19
NO CHANGE
Target $60
EVER
Outperform
Molson Coors may be considering options for European business, says Evercore ISI
Evercore ISI analyst Robert Ottenstein said he believes that Molson Coors may be considering strategic options for its European operations, given the company's prior assertion that its Europe business would be "structured to allow for standalone operations" as part of its "Revitalization Plan." Ottenstein also notes that Carlsberg's CEO replied on his own company's conference call, when asked about speculation that Molson Coors was considering a review of the business, that "we can only share with you that we heard the same, but obviously, we're not commenting on that." Molson Coors' European business, accounts for about 18% of sales and 15% of EBITDA, said the analyst, who estimates that a sale of the European business could be about 15%-20% accretive to EPS, based on his assumptions about a potential price and use of after-tax proceeds. Ottenstein, who sees potential issues with a sale of Europe being the split ownership of the Miller and Coors brands in these markets and reduced global scale, keeps an Outperform rating on Molson Coors shares.
CMA Comerica
$70.06

-0.46 (-0.65%)

11/26/19
MSCO
11/26/19
DOWNGRADE
Target $75
MSCO
Equal Weight
Comerica downgraded to Equal Weight on lack of catalysts at Morgan Stanley
As previously reported, Morgan Stanley analyst Ken Zerbe downgraded Comerica to Equal Weight from Overweight with a price target of $75, down from $77. Driven by its high level of asset sensitivity and its lag to the industry in repricing its deposit costs lower, Zerbe sees "far more" net interest margin compression at Comerica by the end of 2020 than the median he expects at its peers, the analyst tells investors. While the Fed being on pause gives him more confidence in his net interest income assumptions, he sees too few catalysts remaining for the stock given the bulk of the bank's share repurchases are complete, the Fed is still biased toward cutting rates rather than raising, and loan growth is slowing, Zerbe said.
10/18/19
ARGS
10/18/19
DOWNGRADE
ARGS
Hold
Comerica downgraded to Hold from Buy at Argus
11/26/19
MSCO
11/26/19
DOWNGRADE
Target $75
MSCO
Equal Weight
Comerica downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Ken Zerbe downgraded Comerica to Equal Weight from Overweight with a $75 price target.
10/18/19
ARGS
10/18/19
DOWNGRADE
ARGS
Hold
Comerica downgraded to Hold from Buy at Argus
Argus analyst Kevin Heal downgraded Comerica to Hold after its Q3 results, noting that while the company beat on earnings, its net interest income fell 2.2% from last year. The analyst believes that the company will face higher earnings pressure than its peers amid a lower interest rate environment as its net interest margins continue to compress. Heal adds that Comerica's non-interest expenses will be slightly higher among its peer group due to rising processing and technology costs.

TODAY'S FREE FLY STORIES

EDIT

Editas Medicine

$30.34

-0.6 (-1.94%)

18:02
12/09/19
12/09
18:02
12/09/19
18:02
Hot Stocks
Editas Medicine announces in vivo proof-of-concept data for EDIT-301 »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

, CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

17:56
12/09/19
12/09
17:56
12/09/19
17:56
Hot Stocks
Mesabi Trust initiates arbitration against Northshore Mining, Cleveland-Cliffs »

The Trustees of Mesabi…

MSB

Mesabi Trust

$23.93

0.71 (3.06%)

CLF

Cleveland-Cliffs

$8.52

0.38 (4.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$24.67

0.12 (0.49%)

17:51
12/09/19
12/09
17:51
12/09/19
17:51
Hot Stocks
First Financial Bancorp chairman Davis sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRE

Green Plains

$14.26

-0.49 (-3.32%)

17:47
12/09/19
12/09
17:47
12/09/19
17:47
Hot Stocks
Green Plains CEO Todd Becker sold over 607K in company shares »

Green Plains CEO Todd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$111.12

-2.02 (-1.79%)

17:43
12/09/19
12/09
17:43
12/09/19
17:43
Hot Stocks
Medtronic director buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

VAC

Marriott Vacations

$123.77

-0.1 (-0.08%)

17:41
12/09/19
12/09
17:41
12/09/19
17:41
Hot Stocks
Marriott Vacations raises quarterly dividend to 54c from 45c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLY

Fastly

$20.82

-0.35 (-1.65%)

17:36
12/09/19
12/09
17:36
12/09/19
17:36
Hot Stocks
Fastly director Sunil Dhaliwal sells almost $576K in company shares »

Fastly director Sunil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

17:36
12/09/19
12/09
17:36
12/09/19
17:36
Hot Stocks
Stitch Fix says saw healthy growth in both women's, men's categories »

Says shows online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

  • 12

    Dec

  • 19

    Dec

F

Ford

$9.00

-0.015 (-0.17%)

17:32
12/09/19
12/09
17:32
12/09/19
17:32
Hot Stocks
Ford expects to roughly halve 2018 China EBIT loss »

During a meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 07

    Jan

  • 04

    Feb

VEEV

Veeva

$143.56

-1.115 (-0.77%)

17:28
12/09/19
12/09
17:28
12/09/19
17:28
Hot Stocks
Veeva CMO sells 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BLDR

Builders FirstSource

$25.71

0.45 (1.78%)

17:25
12/09/19
12/09
17:25
12/09/19
17:25
Hot Stocks
Builders FirstSource acquires assets of Raney Components, Construction »

Builders FirstSource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

S

Sprint

$5.40

-0.145 (-2.62%)

, TMUS

T-Mobile

$75.90

-1.87 (-2.40%)

17:16
12/09/19
12/09
17:16
12/09/19
17:16
Periodicals
Judge seeks speedy trial over T-Mobile, Sprint deal, WSJ reports »

U.S. District Judge…

S

Sprint

$5.40

-0.145 (-2.62%)

TMUS

T-Mobile

$75.90

-1.87 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 16

    Dec

WEN

Wendy's

$21.72

0.15 (0.70%)

17:15
12/09/19
12/09
17:15
12/09/19
17:15
Hot Stocks
Wendy's sees FY20 FCF of $210M-$220M including impact of settlement »

As a result of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BANX

StoneCastle

$22.99

0.25 (1.10%)

17:15
12/09/19
12/09
17:15
12/09/19
17:15
Hot Stocks
Breaking Hot Stocks news story on StoneCastle »

StoneCastle trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIZ

Assurant

$130.91

-0.66 (-0.50%)

17:14
12/09/19
12/09
17:14
12/09/19
17:14
Hot Stocks
Assurant director sells 21.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XAIR

Beyond Air

$4.13

0.005 (0.12%)

17:14
12/09/19
12/09
17:14
12/09/19
17:14
Syndicate
Beyond Air announces offering of common stock, concurrent private placement »

Beyond Air announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$151.35

-0.42 (-0.28%)

, UPWK

Upwork

$11.15

-0.16 (-1.41%)

17:10
12/09/19
12/09
17:10
12/09/19
17:10
Hot Stocks
Upwork CEO Stephane Kasriel to step down, Hayden Brown to succeed »

Upwork (UPWK) announced…

MSFT

Microsoft

$151.35

-0.42 (-0.28%)

UPWK

Upwork

$11.15

-0.16 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AMZN

Amazon.com

$1,749.61

-1.18 (-0.07%)

, MSFT

Microsoft

$151.35

-0.42 (-0.28%)

17:10
12/09/19
12/09
17:10
12/09/19
17:10
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks slid to kick off…

AMZN

Amazon.com

$1,749.61

-1.18 (-0.07%)

MSFT

Microsoft

$151.35

-0.42 (-0.28%)

ARQL

ArQule

$19.71

10.035 (103.77%)

THOR

Synthorx

$67.72

42.74 (171.10%)

SNY

Sanofi

$45.30

-0.755 (-1.64%)

DPLO

Diplomat Pharmacy

$3.91

-1.91 (-32.82%)

UNH

UnitedHealth

$277.56

-2.62 (-0.94%)

MS

Morgan Stanley

$49.60

-0.2 (-0.40%)

VIAC

ViacomCBS

$38.65

-1.05 (-2.64%)

VIACA

ViacomCBS

$41.78

-1.64 (-3.78%)

FTSV

Forty Seven

$30.44

16.04 (111.39%)

FATE

Fate Therapeutics

$19.32

5.68 (41.64%)

TTWO

Take-Two

$120.07

-3.69 (-2.98%)

THO

Thor Industries

$64.28

-3.485 (-5.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

BANX

StoneCastle

$22.99

0.25 (1.10%)

17:09
12/09/19
12/09
17:09
12/09/19
17:09
Hot Stocks
ArrowMark Partners to acquire StoneCastle Asset Management »

StoneCastle Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$21.72

0.15 (0.70%)

17:08
12/09/19
12/09
17:08
12/09/19
17:08
Hot Stocks
Wendy's to realign resources in its information technology organization »

On December 5, the Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

INVH

Invitation Homes

$30.14

0.12 (0.40%)

17:05
12/09/19
12/09
17:05
12/09/19
17:05
Hot Stocks
Invitation Homes sells 708 Nashville homes to Tricon for $210M »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRO

Brown & Brown

$38.22

-0.14 (-0.36%)

17:04
12/09/19
12/09
17:04
12/09/19
17:04
Hot Stocks
Brown & Brown enters agreement to acquire Special Risk Insurance Managers »

J. Scott Penny, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PYX

Pyxus

$7.40

-0.345 (-4.45%)

, PM

Philip Morris

$83.60

0.34 (0.41%)

17:02
12/09/19
12/09
17:02
12/09/19
17:02
Hot Stocks
Alliance One expands relationship with Philip Morris' Argentine affiliate »

Alliance One…

PYX

Pyxus

$7.40

-0.345 (-4.45%)

PM

Philip Morris

$83.60

0.34 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$89.69

0.2 (0.22%)

17:01
12/09/19
12/09
17:01
12/09/19
17:01
Hot Stocks
Tyson Fresh Meats signs agreement with Republic of Kazakhstan »

Tyson Fresh Meats, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AES

AES Corp.

$18.79

0.07 (0.37%)

17:01
12/09/19
12/09
17:01
12/09/19
17:01
Hot Stocks
AES Corp. raises quarterly dividend 5% to 14.33 per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.